With brand name GLP-1 medications costing $900-$1,300 per month without insurance, compounded semaglutide and tirzepatide have become extremely popular. But how safe are they? Here is what the FDA, clinical studies, and regulatory agencies have to say.
What Is Compounded Semaglutide?
Compounded semaglutide is not FDA-approved. It is produced by licensed compounding pharmacies using semaglutide base (the active ingredient) purchased from bulk suppliers. These pharmacies are regulated at the state level, not by the FDA, and their products do not undergo the same safety, efficacy, and quality testing as brand-name drugs.
The FDA Warning
The FDA has issued multiple warnings about compounded semaglutide:
- Salt forms vs base: Many compounding pharmacies use semaglutide sodium or semaglutide acetate (salt forms), not the semaglutide base used in FDA-approved drugs. The safety and efficacy of these salt forms have not been established.
- Dosing errors: The FDA has received reports of adverse events from patients using compounded semaglutide who received incorrect doses due to compounding errors.
- Sterility concerns: Multiple compounding pharmacies have been cited for sterility violations that could lead to serious infections.
Brand Name: What You Get with FDA Approval
Brand name GLP-1 medications (Wegovy, Ozempic, Mounjaro, Zepbound) undergo:
- Phase 1, 2, and 3 clinical trials (thousands of patients)
- Rigorous manufacturing quality controls (FDA-inspected facilities)
- Consistent potency and dosing (each batch tested)
- Sterility guaranteed (single-use pens with preservatives)
- Ongoing safety monitoring (FDA Adverse Event Reporting System)
- Long-term cardiovascular outcomes data (SELECT trial for semaglutide)
Is Compounded Semaglutide Safe?
A 2024 study published in JAMA Network Open (Bhasin et al.) analyzed 10 samples of compounded semaglutide from different pharmacies. The findings were concerning:
- 40% of samples contained different concentrations than labeled
- Some samples contained semaglutide salt forms not used in any clinical trial
- Variability between batches from the same pharmacy was significant
However, it is important to note that many patients have used compounded semaglutide without reported issues. The key distinction is that compounded versions have not been studied in controlled trials, so their safety profile is unknown.
Cost Comparison
| Option | Monthly Cost (without insurance) |
|---|---|
| Wegovy (brand, FDA-approved) | $1,300+ |
| Ozempic (brand, FDA-approved) | $900+ |
| Zepbound (brand, FDA-approved) | $1,060+ |
| Henry Meds (compounded, flat rate) | $297 flat |
| Local compounding pharmacy | $150-$300 |
How to Choose Safely
- If cost is not an issue: Choose brand name. You get proven efficacy, safety data, and consistent quality.
- If you need a lower-cost option: Choose a reputable telehealth provider like Henry Meds that works with accredited 503A compounding pharmacies and provides medical oversight.
- Red flags to avoid: Buying from online marketplaces, social media sellers, or any source that does not require a prescription.
- Ask your pharmacy: Are you using semaglutide base or a salt form? Do you test each batch for potency? Are you accredited by PCAB (Pharmacy Compounding Accreditation Board)?
References:
1. FDA. Medication Alert: Compounded Semaglutide Products. FDA.gov, 2024.
2. Bhasin S, et al. Analysis of Compounded Semaglutide Samples. JAMA Network Open, 2024.
3. FDA. FDA Concerns About Compounded GLP-1 Drugs. FDA Drug Safety Communication, 2023.